In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Berger Montague
- BoiesBattin
- Boies Schiller
- Cohen Milstein
- Crenshaw Ware
- Crowell & Moring
- DLA Piper
- Duncan & Allen
- Durrette Arkema
- DurretteCrump
- Faruqi & Faruqi
- Fisher & Phillips
- Furniss Davis
- Garwin Gerstein
- Gibson Dunn
- Girard Sharp
- Glancy Prongay
- Glasser & Glasser
- Goldman Ismail
- Grabar Law
- Gustafson Gluek
- Hagens Berman
- Hangley Aronchick
- Hartley LLP
- Heins Mills
- Hilliard & Shadowen
- Joseph Saveri Law Firm
- Katten Muchin
- Kaufman & Canoles
- Kenny Nachwalter
- Kessler Topaz
- Kirkland & Ellis
- Labaton Keller
- Lockridge Grindal
- Marcus & Shapira
- McDermott Will & Emery
- McGuireWoods
- Miller Shah LLP
- Morgan Lewis
- Motley Rice
- Nussbaum Law Group
- O'Hagan Meyer
- Radice Law Firm
- Smith Segura
- Sperling & Slater
- Taus Cebulash
- The Office of Craig C. Reilly
- Vanek Vickers
- Ventker Henderson
- Wexler Boley
- White & Case
- Willcox & Savage
- Williams & Connolly
- Wilson Sonsini
- Winston & Strawn
- Wolcott Rivers
- Woods Rogers
- Zelle LLP
Companies
- Albertsons Cos. Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Centene Corp.
- CVS Health Corp.
- Fraternal Order of Police
- Giant Eagle Inc.
- Glenmark Pharmaceuticals Ltd.
- H.D. Smith LLC
- Health Net Inc.
- H‑E‑B LP
- Humana Inc.
- J.M. Smith Corp.
- McKesson Corp.
- Merck & Co. Inc.
- Mutual Drug
- Par Pharmaceutical Cos. Inc.
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Supervalu Inc.
- The Kroger Co.
- United Food & Commercial Workers International Union
- Wegmans Food Markets Inc.
- WellCare Health Plans Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
November 02, 2018
Zetia MDL Buyers Maintain Merck's Generic Deal Was Illegal
A Virginia federal court shouldn't throw out multidistrict litigation accusing Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. of manipulating the generic drug market to keep prices of the cholesterol medication Zetia high, buyers of the drug urged, claiming they can prove antitrust violations.
-
October 12, 2018
Merck, Glenmark Tear Apart Zetia Pay-For-Delay MDL Claims
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. have asked a Virginia federal court to throw out three complaints in multidistrict litigation accusing them of entering into an illegal reverse-payment deal to keep a generic version of the cholesterol drug Zetia off the market.
-
July 30, 2018
Lawyers Compete To Represent Zetia Buyers In Antitrust Case
More than a half-dozen law firms representing buyers of the cholesterol drug Zetia launched competing bids Friday to act as interim counsel for end payors for the drug in an antitrust MDL accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.
-
July 03, 2018
Direct Drug Purchasers Aim For Consolidation In Zetia MDL
A putative class of direct purchasers of the cholesterol drug Zetia asked a Virginia federal judge on Monday to consolidate their antitrust claims accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.